Biogen's blood disorder drug succeeds in late-stage trial

http://bit.ly/13Y6UVy

#boise #idaho

Boise Bipolar Center, Charles K. Bunch, Ph.D, Boise Idaho Therapist Mental health photo 2168_zps680c452f.jpg


Health News Headlines - Yahoo News




Biogen's blood disorder drug succeeds in late-stage trial



(Reuters) - Biogen Idec Inc and Swedish Orphan Biovitrum said their experimental blood disorder drug was effective in maintaining low bleeding rates in children in a late-stage trial. The drug, Eloctate, was being developed as a treatment for haemophilia A - a rare genetic disorder in which a person's blood does not clot properly due to missing or reduced levels of a particular protein. (Reporting by Esha Dey in Bangalore; Editing by Saumyadeb Chakrabarty)










#mentalhealth

http://bit.ly/13Y6UVy Boise Bipolar Center, Charles K. Bunch, Ph.D, Boise Idaho Therapist Mental health photo 2168_zps680c452f.jpg



from Anxiety Agoraphobia Bipolar Disorder Evaluations and Treatment in Boise, Treasure Valley, Idaho http://ift.tt/1k8wgvd